Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

275.54
BATS BZX Real-Time Price
As of 12:47pm ET
 +0.13 / +0.05%
Today’s Change
205.42
Today|||52-Week Range
307.33
+5.49%
Year-to-Date
Stock Market News for March 24, 2017
10:49am / Zacks.com - Paid Partner Content
European Stocks Drift Lower; Deutsche Bank Falls on Rights Issue Details
Mar 20 / TheStreet.com - Paid Partner Content
Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results
Mar 22 / Zacks.com - Paid Partner Content
European Stocks Set For Mixed Open: Dollar Slumps in Quiet Asia Trade
Mar 20 / TheStreet.com - Paid Partner Content
Five Stocks I Like on the Nasdaq Market
Mar 21 / GuruFocus News - Paid Partner Content
Alkermes Starts Phase III Study to Treat Multiple Sclerosis
Mar 17 / Zacks.com - Paid Partner Content
3 Biotech Stocks That Are Broker Favorites
Mar 21 / Zacks.com - Paid Partner Content
Week in Review: Stocks Post Small Gains After Fed Pulls Trigger on Third Hike Since C...
Mar 17 / TheStreet.com - Paid Partner Content
Trump, Biogen and Amgen Hammer Healthcare ETFs
Mar 20 / Zacks.com - Paid Partner Content
Dow, S&P 500 Decline as Health Care Losses Counter Gains
Mar 17 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close275.41
Today’s open277.77
Day’s range275.12 - 278.01
Volume33,709
Average volume (3 months)1,779,331
Market cap$59.5B
Dividend yield--
Data as of 12:47pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+10.32%
Earnings growth (this year)+3.58%
Earnings growth (next 5 years)+8.72%
Revenue growth (last year)+9.37%
P/E ratio17.7
Price/Sales6.09
Price/Book4.90

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.16+0.24%
ILMNIllumina Inc+3.61+2.15%
BIVVBioverativ Inc-0.39-0.77%
KITEKite Pharma Inc+2.44+3.28%
Data as of 12:49pm ET, 03/24/2017

Financials

Next reporting dateApril 27, 2017
EPS forecast (this quarter)$5.00
Annual revenue (last year)$10.2B
Annual profit (last year)$3.7B
Net profit margin36.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michel Vounatsos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs